Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:AKER

Akers Biosciences (AKER) Stock Price, News & Analysis

Akers Biosciences logo

About Akers Biosciences Stock (NASDAQ:AKER)

Advanced Chart

Key Stats

Today's Range
$0.04
$0.05
50-Day Range
$2.47
$4.59
52-Week Range
$1.65
$6.97
Volume
71.27 million shs
Average Volume
769,876 shs
Market Capitalization
$804.34 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive AKER Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Akers Biosciences and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

AKER Stock News Headlines

Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.tc pixel
Cam Akers Not Worth A Look In Week 10
See More Headlines

AKER Stock Analysis - Frequently Asked Questions

Akers Biosciences, Inc. (NASDAQ:AKER) released its quarterly earnings data on Thursday, November, 15th. The medical instruments supplier reported ($0.26) earnings per share (EPS) for the quarter. The medical instruments supplier had revenue of $0.56 million for the quarter.

Based on aggregate information from My MarketBeat watchlists, some other companies that Akers Biosciences investors own include Sorrento Therapeutics (SRNE), Aytu BioPharma (AYTU), ImmunoGen (IMGN), AVEO Pharmaceuticals (AVEO), Advanced Micro Devices (AMD), Vaxart (VXRT) and Neovasc (NVCN).

Company Calendar

Last Earnings
11/15/2018
Today
8/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Diagnostic Substances
Sub-Industry
N/A
Current Symbol
NASDAQ:AKER
CIK
1321834
Fax
N/A
Employees
4
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$3.89 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-87.42%
Return on Assets
-73.31%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
9.22
Quick Ratio
9.22

Sales & Book Value

Annual Sales
$1.58 million
Price / Sales
0.51
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$5.38 per share
Price / Book
0.01

Miscellaneous

Outstanding Shares
16,653,000
Free Float
N/A
Market Cap
$804.34 thousand
Optionable
Not Optionable
Beta
0.30
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:AKER) was last updated on 8/31/2025 by MarketBeat.com Staff
From Our Partners